We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th:
Quidel Corporation (QDEL - Free Report) : This diagnostic testing solutions developer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Owens & Minor, Inc. (OMI - Free Report) : This healthcare solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 69.4% over the last 60 days.
Charles & Colvard, Ltd. (CTHR - Free Report) : This moissanite jewels and finished jewelries manufacturer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
SYNNEX Corporation (SNX - Free Report) : This business process services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 14% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Shutterstock
Top Ranked Momentum Stocks to Buy for October 6th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th:
Quidel Corporation (QDEL - Free Report) : This diagnostic testing solutions developer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Quidel Corporation Price and Consensus
Quidel Corporation price-consensus-chart | Quidel Corporation Quote
Quidel’s shares gained nearly 63% over the last one month compared with the S&P 500’s decline of 0.5%. The company possesses a Momentum Score of A.
Quidel Corporation Price
Quidel Corporation price | Quidel Corporation Quote
Owens & Minor, Inc. (OMI - Free Report) : This healthcare solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 69.4% over the last 60 days.
Owens Minor, Inc. Price and Consensus
Owens Minor, Inc. price-consensus-chart | Owens Minor, Inc. Quote
Owens & Minor’s shares gained 46.5% over the last one month. The company possesses a Momentum Score of A.
Owens Minor, Inc. Price
Owens Minor, Inc. price | Owens Minor, Inc. Quote
Charles & Colvard, Ltd. (CTHR - Free Report) : This moissanite jewels and finished jewelries manufacturer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
Charles Colvard Ltd Price and Consensus
Charles Colvard Ltd price-consensus-chart | Charles Colvard Ltd Quote
Charles & Colvard’s shares gained 30.9% over the last one month. The company possesses a Momentum Score of A.
Charles Colvard Ltd Price
Charles Colvard Ltd price | Charles Colvard Ltd Quote
SYNNEX Corporation (SNX - Free Report) : This business process services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 14% over the last 60 days.
SYNNEX Corporation Price and Consensus
SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote
Synnex’s shares gained 20.3% over the last one month. The company possesses a Momentum Score of A.
SYNNEX Corporation Price
SYNNEX Corporation price | SYNNEX Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>